Products testings/Clinical trials

SORATINEX products have been tested in several European hospitals and clinics by experts in dermatology. The results show efficacy of more than 80% which is an unprecedented figure for a non-medical product. Our psoriasis products, branded under the name “SORATINEX”, have also been shown to be a safe and effective treatment option for psoriasis.

Results from SORATINEX trials have been published in the Journal of Biological Regulators and Homeostatic Agents (JBRHA) (http://www.biolifesas.org/contentsJBRHA.html) an influential medical journal. These papers form part of the body of scientific evidence demonstrating the efficacy of SORATINEX products. The papers have also been published in PubMed (US National Library of Medicine, National Institute of Health and are available at the following links:

https://www.ncbi.nlm.nih.gov/m/pubmed/27498651/?i=4&from=/27498657/related

https://www.ncbi.nlm.nih.gov/m/pubmed/27498661/?i=2&from=/27498651/related

https://www.ncbi.nlm.nih.gov/m/pubmed/27498662/?i=2&from=/27498661/related